These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 35460405

  • 21. CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL).
    Ranuhardy D, Suzanna E, Sari RM, Hadisantoso DW, Andalucia R, Abdillah A.
    Acta Med Indones; 2018 Apr; 50(2):104-109. PubMed ID: 29950528
    [Abstract] [Full Text] [Related]

  • 22. ALK-negative anaplastic large cell lymphoma, null type with aberrant expression of PAX5 and CD138: A diagnostic pitfall.
    Salyana MA, Khan S, Zhang X.
    Diagn Cytopathol; 2021 Oct; 49(10):E395-E399. PubMed ID: 34190415
    [Abstract] [Full Text] [Related]

  • 23. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms.
    Desouki MM, Post GR, Cherry D, Lazarchick J.
    Clin Med Res; 2010 Jul; 8(2):84-8. PubMed ID: 20660931
    [Abstract] [Full Text] [Related]

  • 24. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ, Ouyang J, Juszczynski P, Currie T, Law K, Neuberg DS, Rabinovich GA, Shipp MA, Kutok JL.
    Clin Cancer Res; 2008 Jun 01; 14(11):3338-44. PubMed ID: 18519761
    [Abstract] [Full Text] [Related]

  • 25. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
    Xing X, Feldman AL.
    Adv Anat Pathol; 2015 Jan 01; 22(1):29-49. PubMed ID: 25461779
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M.
    Blood; 1995 Sep 15; 86(6):2321-8. PubMed ID: 7662979
    [Abstract] [Full Text] [Related]

  • 28. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL.
    Blood; 2014 Aug 28; 124(9):1473-80. PubMed ID: 24894770
    [Abstract] [Full Text] [Related]

  • 29. Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.
    Tamaru J, Tokuhira M, Nittsu N, Nakamura S, Ichinohasama R, Suzuki R, Mori H, Takagi T, Suzuki T, Itami J, Itoyama S, Mikata A.
    Leuk Lymphoma; 2007 Jun 28; 48(6):1127-38. PubMed ID: 17577776
    [Abstract] [Full Text] [Related]

  • 30. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
    Drakos E, Leventaki V, Schlette EJ, Jones D, Lin P, Medeiros LJ, Rassidakis GZ.
    Am J Surg Pathol; 2007 Mar 28; 31(3):447-53. PubMed ID: 17325487
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls.
    Montella M, Lucà S, Ronchi A, Marino FZ, Caputo A, Sica A, Zeppa P, Franco R, Cozzolino I.
    Acta Cytol; 2023 Mar 28; 67(3):230-239. PubMed ID: 36634640
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A, Gloghini A, Volpe R.
    Cancer; 1992 Dec 01; 70(11):2691-8. PubMed ID: 1330287
    [Abstract] [Full Text] [Related]

  • 36. American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.
    O'Malley DP, Dogan A, Fedoriw Y, Medeiros LJ, Ok CY, Salama ME.
    Ann Diagn Pathol; 2019 Apr 01; 39():105-110. PubMed ID: 30802809
    [Abstract] [Full Text] [Related]

  • 37. Epstein-Barr virus infection patterns in nodular lymphocyte-predominant Hodgkin lymphoma.
    Gerhard-Hartmann E, Jöhrens K, Schinagl LM, Zamó A, Rosenwald A, Anagnostopoulos I, Rosenfeldt M.
    Histopathology; 2022 Jun 01; 80(7):1071-1080. PubMed ID: 35322462
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
    Lai R, Medeiros LJ, Dabbagh L, Formenti KS, Coupland RW.
    Mod Pathol; 2000 Mar 01; 13(3):223-8. PubMed ID: 10757332
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.